Simoa® assays can detect neurological biomarkers, such as Neurofilament Light (NfL), GFAP and several others associated with brain injury and disease. With Simoa®, these informative markers can be detected at much earlier stages, in serum or plasma, enabling better understanding of the long-term effects and disease pathology without invasive measures. Download our flyer to learn more about the application of bead technology for multiple sclerosis research and view a sampling of recent publications.
Related Posts
Akoya PhenoImager-HT 2.0 Brochure
Akoya PhenoImager-HT 2.0 Brochure
Akoya PhenoImager-HT 2.0 Brochure
Human Neurobiology PhenoCode Discovery Panel
Human Neurobiology PhenoCode Discovery Panel
Human Neurobiology PhenoCode Discovery Panel
Building Custom High-Plex Biomarker Panels
Building Custom High-Plex Biomarker Panels
Building Custom High-Plex Biomarker Panels
Scale Your Spatial Discoveries with Molecular Barcoding
Scale Your Spatial Discoveries with Molecular Barcoding
Scale Your Spatial Discoveries with Molecular Barcoding
PhenoCode Molecular Barcoding Kit
Spatial Analysis
Spatial Analysis
PhenoCode Molecular Barcoding Kit
PhenoCode Molecular Barcoding Kit
Introducing the Metabolism Spike-in Module for IO60
Download Brochure
Introducing the Metabolism Spike-in Module for IO60
NfL Fact Sheet
Neurology
Download Brochure
Neurology
NfL Fact Sheet
Neurofilament light (NfL) has emerged in recent years as a blood-based biomarker with the potential to aid in the improvement of early diagnosis and patient care of neuro-axonal injury and…
Cytokine 4-Plex Advantage PLUS Product Flyer
Neurology
Download Brochure
Neurology
Cytokine 4-Plex Advantage PLUS Product Flyer
Ultra-Sensitive, Fully Automated Simoa® Cytokine 4-Plex Advantage PLUS Assays Three panels, 11 essential cytokine biomarkers, femtogram sensitivity With Simoa® ultra-sensitive protein quantification, the cutting-edge Advantage PLUS assay platform, and full…